HEADER HYDROLASE/INHIBITOR 28-JUN-23 8TBF TITLE TRICOMPLEX OF RMC-7977, KRAS WT, AND CYPA COMPND MOL_ID: 1; COMPND 2 MOLECULE: GTPASE KRAS; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: K-RAS 2,KI-RAS,C-K-RAS,C-KI-RAS; COMPND 5 EC: 3.6.5.2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE A; COMPND 9 CHAIN: C, D; COMPND 10 SYNONYM: PPIASE A,CYCLOPHILIN A,CYCLOSPORIN A-BINDING PROTEIN, COMPND 11 ROTAMASE A; COMPND 12 EC: 5.2.1.8; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KRAS, KRAS2, RASK2; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: PPIA, CYPA; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS INHIBITOR, COMPLEX, SMALL GTPASE, CANCER, TRICOMPLEX, HYDROLASE- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.C.A.TOMLINSON,A.CHEN,J.E.KNOX,J.K.YANO REVDAT 3 24-APR-24 8TBF 1 JRNL REVDAT 2 17-APR-24 8TBF 1 JRNL REVDAT 1 07-FEB-24 8TBF 0 JRNL AUTH M.HOLDERFIELD,B.J.LEE,J.JIANG,A.TOMLINSON,K.J.SEAMON,A.MIRA, JRNL AUTH 2 E.PATRUCCO,G.GOODHART,J.DILLY,Y.GINDIN,N.DINGLASAN,Y.WANG, JRNL AUTH 3 L.P.LAI,S.CAI,L.JIANG,N.NASHOLM,N.SHIFRIN,C.BLAJ,H.SHAH, JRNL AUTH 4 J.W.EVANS,N.MONTAZER,O.LAI,J.SHI,E.AHLER,E.QUINTANA,S.CHANG, JRNL AUTH 5 A.SALVADOR,A.MARQUEZ,J.CREGG,Y.LIU,A.MILIN,A.CHEN,T.B.ZIV, JRNL AUTH 6 D.PARSONS,J.E.KNOX,J.E.KLOMP,J.ROTH,M.REES,M.RONAN, JRNL AUTH 7 A.CUEVAS-NAVARRO,F.HU,P.LITO,D.SANTAMARIA,A.J.AGUIRRE, JRNL AUTH 8 A.M.WATERS,C.J.DER,C.AMBROGIO,Z.WANG,A.L.GILL,E.S.KOLTUN, JRNL AUTH 9 J.A.M.SMITH,D.WILDES,M.SINGH JRNL TITL CONCURRENT INHIBITION OF ONCOGENIC AND WILD-TYPE RAS-GTP FOR JRNL TITL 2 CANCER THERAPY. JRNL REF NATURE 2024 JRNL REFN ESSN 1476-4687 JRNL PMID 38589574 JRNL DOI 10.1038/S41586-024-07205-6 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J.JIANG,L.JIANG,B.J.MALDONATO,Y.WANG,M.HOLDERFIELD, REMARK 1 AUTH 2 I.ARONCHIK,I.P.WINTERS,Z.SALMAN,C.BLAJ,M.MENARD,J.BRODBECK, REMARK 1 AUTH 3 Z.CHEN,X.WEI,M.J.ROSEN,Y.GINDIN,B.J.LEE,J.W.EVANS,S.CHANG, REMARK 1 AUTH 4 Z.WANG,K.J.SEAMON,D.PARSONS,J.CREGG,A.MARQUEZ, REMARK 1 AUTH 5 A.C.A.TOMLINSON,J.K.YANO,J.E.KNOX,E.QUINTANA,A.J.AGUIRRE, REMARK 1 AUTH 6 K.C.ARBOUR,A.REED,W.C.GUSTAFSON,A.L.GILL,E.S.KOLTUN, REMARK 1 AUTH 7 D.WILDES,J.A.M.SMITH,Z.WANG,M.SINGH REMARK 1 TITL TRANSLATIONAL AND THERAPEUTIC EVALUATION OF RAS-GTP REMARK 1 TITL 2 INHIBITION BY RMC-6236 IN RAS-DRIVEN CANCERS. REMARK 1 REF CANCER DISCOV OF1 2024 REMARK 1 REFN ESSN 2159-8290 REMARK 1 PMID 38593348 REMARK 1 DOI 10.1158/2159-8290.CD-24-0027 REMARK 2 REMARK 2 RESOLUTION. 1.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.17.1_3660 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 58.29 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 112256 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.179 REMARK 3 R VALUE (WORKING SET) : 0.178 REMARK 3 FREE R VALUE : 0.210 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.910 REMARK 3 FREE R VALUE TEST SET COUNT : 5517 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 58.2900 - 4.6600 0.99 3782 193 0.1719 0.1840 REMARK 3 2 4.6600 - 3.7000 1.00 3655 200 0.1527 0.1822 REMARK 3 3 3.7000 - 3.2300 1.00 3646 181 0.1746 0.2071 REMARK 3 4 3.2300 - 2.9400 1.00 3622 188 0.1775 0.2251 REMARK 3 5 2.9400 - 2.7300 1.00 3593 192 0.1784 0.1849 REMARK 3 6 2.7300 - 2.5600 1.00 3606 172 0.1841 0.2307 REMARK 3 7 2.5600 - 2.4400 1.00 3584 176 0.1779 0.2323 REMARK 3 8 2.4400 - 2.3300 1.00 3565 180 0.1755 0.2359 REMARK 3 9 2.3300 - 2.2400 1.00 3602 183 0.1766 0.1924 REMARK 3 10 2.2400 - 2.1600 1.00 3534 194 0.1728 0.2332 REMARK 3 11 2.1600 - 2.1000 1.00 3565 186 0.1845 0.2228 REMARK 3 12 2.1000 - 2.0400 1.00 3563 186 0.1898 0.2377 REMARK 3 13 2.0400 - 1.9800 1.00 3544 166 0.1869 0.2237 REMARK 3 14 1.9800 - 1.9300 1.00 3536 184 0.1849 0.2066 REMARK 3 15 1.9300 - 1.8900 1.00 3589 175 0.1880 0.1762 REMARK 3 16 1.8900 - 1.8500 1.00 3528 174 0.1781 0.2168 REMARK 3 17 1.8500 - 1.8100 1.00 3555 181 0.1845 0.2224 REMARK 3 18 1.8100 - 1.7800 1.00 3499 182 0.1886 0.2050 REMARK 3 19 1.7800 - 1.7500 1.00 3550 190 0.1970 0.2396 REMARK 3 20 1.7500 - 1.7200 1.00 3512 192 0.1888 0.2260 REMARK 3 21 1.7200 - 1.6900 1.00 3522 188 0.1825 0.2210 REMARK 3 22 1.6900 - 1.6600 1.00 3544 183 0.1800 0.2057 REMARK 3 23 1.6600 - 1.6400 1.00 3496 186 0.1791 0.2160 REMARK 3 24 1.6400 - 1.6200 1.00 3533 169 0.1874 0.2298 REMARK 3 25 1.6200 - 1.5900 1.00 3476 195 0.1884 0.2129 REMARK 3 26 1.5900 - 1.5700 1.00 3528 193 0.1950 0.2110 REMARK 3 27 1.5700 - 1.5500 0.99 3531 178 0.1999 0.2485 REMARK 3 28 1.5500 - 1.5300 1.00 3486 186 0.2029 0.2483 REMARK 3 29 1.5300 - 1.5200 0.99 3488 178 0.2153 0.2755 REMARK 3 30 1.5200 - 1.5000 1.00 3505 186 0.2294 0.2781 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.147 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.771 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 17.58 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.56 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.006 5650 REMARK 3 ANGLE : 0.939 7654 REMARK 3 CHIRALITY : 0.058 819 REMARK 3 PLANARITY : 0.005 984 REMARK 3 DIHEDRAL : 13.937 2174 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: (CHAIN 'A' AND RESID 0 THROUGH 169) REMARK 3 ORIGIN FOR THE GROUP (A): 21.1441 -5.9975 -10.0257 REMARK 3 T TENSOR REMARK 3 T11: 0.1079 T22: 0.0981 REMARK 3 T33: 0.1390 T12: -0.0272 REMARK 3 T13: 0.0317 T23: 0.0089 REMARK 3 L TENSOR REMARK 3 L11: 1.8572 L22: 2.2938 REMARK 3 L33: 2.1224 L12: -0.3676 REMARK 3 L13: -0.2303 L23: 0.2968 REMARK 3 S TENSOR REMARK 3 S11: 0.0854 S12: 0.0326 S13: 0.2535 REMARK 3 S21: -0.0144 S22: 0.0496 S23: -0.2022 REMARK 3 S31: -0.2205 S32: 0.1068 S33: -0.1063 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: (CHAIN 'B' AND RESID 0 THROUGH 169) REMARK 3 ORIGIN FOR THE GROUP (A): 17.4396 -23.5404 -42.3181 REMARK 3 T TENSOR REMARK 3 T11: 0.3611 T22: 0.1915 REMARK 3 T33: 0.1584 T12: 0.0851 REMARK 3 T13: -0.0019 T23: -0.0022 REMARK 3 L TENSOR REMARK 3 L11: 3.2725 L22: 3.6246 REMARK 3 L33: 2.7300 L12: -2.1692 REMARK 3 L13: 0.2566 L23: -0.2472 REMARK 3 S TENSOR REMARK 3 S11: 0.4149 S12: 0.4929 S13: -0.0774 REMARK 3 S21: -0.9135 S22: -0.3301 S23: 0.1426 REMARK 3 S31: -0.0358 S32: 0.0165 S33: -0.0780 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: (CHAIN 'C' AND RESID 1 THROUGH 164) REMARK 3 ORIGIN FOR THE GROUP (A): -9.9042 -15.8396 -24.7485 REMARK 3 T TENSOR REMARK 3 T11: 0.0803 T22: 0.1210 REMARK 3 T33: 0.0979 T12: 0.0142 REMARK 3 T13: 0.0030 T23: 0.0145 REMARK 3 L TENSOR REMARK 3 L11: 1.8550 L22: 1.5870 REMARK 3 L33: 1.8282 L12: 0.5422 REMARK 3 L13: 0.1270 L23: -0.2456 REMARK 3 S TENSOR REMARK 3 S11: 0.0894 S12: -0.1918 S13: -0.0622 REMARK 3 S21: 0.0188 S22: -0.1190 S23: 0.0868 REMARK 3 S31: 0.0719 S32: -0.0537 S33: 0.0261 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: (CHAIN 'D' AND RESID 2 THROUGH 165) REMARK 3 ORIGIN FOR THE GROUP (A): 24.4444 -39.1495 -10.0677 REMARK 3 T TENSOR REMARK 3 T11: 0.1451 T22: 0.0770 REMARK 3 T33: 0.1101 T12: -0.0291 REMARK 3 T13: -0.0178 T23: -0.0045 REMARK 3 L TENSOR REMARK 3 L11: 2.0324 L22: 0.9054 REMARK 3 L33: 2.0395 L12: 0.3149 REMARK 3 L13: 0.3590 L23: 0.1308 REMARK 3 S TENSOR REMARK 3 S11: 0.0099 S12: -0.0116 S13: -0.2310 REMARK 3 S21: 0.0505 S22: 0.0256 S23: 0.0080 REMARK 3 S31: 0.3254 S32: -0.1501 S33: -0.0350 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8TBF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-JUN-23. REMARK 100 THE DEPOSITION ID IS D_1000275619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-23 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CLSI REMARK 200 BEAMLINE : 08ID-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95375 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 9M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 112271 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.500 REMARK 200 RESOLUTION RANGE LOW (A) : 58.290 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 7.300 REMARK 200 R MERGE (I) : 0.05881 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 7.40 REMARK 200 R MERGE FOR SHELL (I) : 0.38870 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 4.540 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.15 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 24% PEG4000, 0.1 M TRIS-HCL, PH 8.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.87850 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 62.99000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 42.12000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.99000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.87850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 42.12000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER C 0 REMARK 465 SER D 0 REMARK 465 MET D 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 108 73.95 -114.78 REMARK 500 LYS A 117 34.56 70.63 REMARK 500 SER A 122 44.37 -97.13 REMARK 500 ASP B 108 71.84 -107.75 REMARK 500 LYS B 117 37.02 73.22 REMARK 500 SER B 122 48.00 -92.17 REMARK 500 PHE C 60 -68.01 -131.89 REMARK 500 ASN C 71 10.68 -144.13 REMARK 500 LYS C 133 -60.11 -98.06 REMARK 500 PHE D 60 -66.78 -133.33 REMARK 500 PHE D 60 -68.13 -133.33 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 478 DISTANCE = 5.83 ANGSTROMS REMARK 525 HOH D 540 DISTANCE = 5.98 ANGSTROMS REMARK 525 HOH D 541 DISTANCE = 6.19 ANGSTROMS REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER A 17 OG REMARK 620 2 THR A 35 OG1 82.1 REMARK 620 3 GNP A 201 O1G 172.9 90.9 REMARK 620 4 GNP A 201 O2B 92.0 174.0 95.0 REMARK 620 5 HOH A 332 O 85.2 90.8 93.6 90.0 REMARK 620 6 HOH A 366 O 89.1 90.5 92.4 88.1 173.9 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 202 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 SER B 17 OG REMARK 620 2 THR B 35 OG1 86.9 REMARK 620 3 GNP B 201 O1G 174.5 92.2 REMARK 620 4 GNP B 201 O2B 89.1 176.0 91.7 REMARK 620 5 HOH B 329 O 86.2 95.6 88.5 83.9 REMARK 620 6 HOH B 334 O 92.0 92.1 93.5 88.2 171.9 REMARK 620 N 1 2 3 4 5 DBREF 8TBF A 1 169 UNP P01116 RASK_HUMAN 1 169 DBREF 8TBF B 1 169 UNP P01116 RASK_HUMAN 1 169 DBREF 8TBF C 1 165 UNP P62937 PPIA_HUMAN 1 165 DBREF 8TBF D 1 165 UNP P62937 PPIA_HUMAN 1 165 SEQADV 8TBF SER A 0 UNP P01116 EXPRESSION TAG SEQADV 8TBF SER B 0 UNP P01116 EXPRESSION TAG SEQADV 8TBF SER C 0 UNP P62937 EXPRESSION TAG SEQADV 8TBF SER D 0 UNP P62937 EXPRESSION TAG SEQRES 1 A 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY SEQRES 2 A 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 A 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 A 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS SEQRES 5 A 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 A 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 A 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 A 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 A 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 A 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 A 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 A 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 A 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 A 170 LYS SEQRES 1 B 170 SER MET THR GLU TYR LYS LEU VAL VAL VAL GLY ALA GLY SEQRES 2 B 170 GLY VAL GLY LYS SER ALA LEU THR ILE GLN LEU ILE GLN SEQRES 3 B 170 ASN HIS PHE VAL ASP GLU TYR ASP PRO THR ILE GLU ASP SEQRES 4 B 170 SER TYR ARG LYS GLN VAL VAL ILE ASP GLY GLU THR CYS SEQRES 5 B 170 LEU LEU ASP ILE LEU ASP THR ALA GLY GLN GLU GLU TYR SEQRES 6 B 170 SER ALA MET ARG ASP GLN TYR MET ARG THR GLY GLU GLY SEQRES 7 B 170 PHE LEU CYS VAL PHE ALA ILE ASN ASN THR LYS SER PHE SEQRES 8 B 170 GLU ASP ILE HIS HIS TYR ARG GLU GLN ILE LYS ARG VAL SEQRES 9 B 170 LYS ASP SER GLU ASP VAL PRO MET VAL LEU VAL GLY ASN SEQRES 10 B 170 LYS CYS ASP LEU PRO SER ARG THR VAL ASP THR LYS GLN SEQRES 11 B 170 ALA GLN ASP LEU ALA ARG SER TYR GLY ILE PRO PHE ILE SEQRES 12 B 170 GLU THR SER ALA LYS THR ARG GLN GLY VAL ASP ASP ALA SEQRES 13 B 170 PHE TYR THR LEU VAL ARG GLU ILE ARG LYS HIS LYS GLU SEQRES 14 B 170 LYS SEQRES 1 C 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL SEQRES 2 C 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE SEQRES 3 C 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA SEQRES 4 C 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER SEQRES 5 C 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY SEQRES 6 C 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER SEQRES 7 C 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU SEQRES 8 C 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA SEQRES 9 C 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR SEQRES 10 C 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE SEQRES 11 C 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET SEQRES 12 C 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS SEQRES 13 C 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU SEQRES 1 D 166 SER MET VAL ASN PRO THR VAL PHE PHE ASP ILE ALA VAL SEQRES 2 D 166 ASP GLY GLU PRO LEU GLY ARG VAL SER PHE GLU LEU PHE SEQRES 3 D 166 ALA ASP LYS VAL PRO LYS THR ALA GLU ASN PHE ARG ALA SEQRES 4 D 166 LEU SER THR GLY GLU LYS GLY PHE GLY TYR LYS GLY SER SEQRES 5 D 166 CYS PHE HIS ARG ILE ILE PRO GLY PHE MET CYS GLN GLY SEQRES 6 D 166 GLY ASP PHE THR ARG HIS ASN GLY THR GLY GLY LYS SER SEQRES 7 D 166 ILE TYR GLY GLU LYS PHE GLU ASP GLU ASN PHE ILE LEU SEQRES 8 D 166 LYS HIS THR GLY PRO GLY ILE LEU SER MET ALA ASN ALA SEQRES 9 D 166 GLY PRO ASN THR ASN GLY SER GLN PHE PHE ILE CYS THR SEQRES 10 D 166 ALA LYS THR GLU TRP LEU ASP GLY LYS HIS VAL VAL PHE SEQRES 11 D 166 GLY LYS VAL LYS GLU GLY MET ASN ILE VAL GLU ALA MET SEQRES 12 D 166 GLU ARG PHE GLY SER ARG ASN GLY LYS THR SER LYS LYS SEQRES 13 D 166 ILE THR ILE ALA ASP CYS GLY GLN LEU GLU HET GNP A 201 32 HET MG A 202 1 HET GNP B 201 32 HET MG B 202 1 HET EDO C 201 4 HET ZNI C 202 62 HET ZNI D 201 62 HETNAM GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER HETNAM MG MAGNESIUM ION HETNAM EDO 1,2-ETHANEDIOL HETNAM ZNI (1R,5S,6R)-N-[(1P,7S,9S,13S,20M)-20-{5-(4- HETNAM 2 ZNI CYCLOPROPYLPIPERAZIN-1-YL)-2-[(1S)-1- HETNAM 3 ZNI METHOXYETHYL]PYRIDIN-3-YL}-21-ETHYL-17,17-DIMETHYL-8, HETNAM 4 ZNI 14-DIOXO-15-OXA-4-THIA-9,21,27,28- HETNAM 5 ZNI TETRAAZAPENTACYCLO[17.5.2.1~2,5~.1~9,13~.0~22, HETNAM 6 ZNI 26~]OCTACOSA-1(24),2,5(28),19,22,25-HEXAEN-7-YL]-3- HETNAM 7 ZNI OXABICYCLO[3.1.0]HEXANE-6-CARBOXAMIDE HETSYN EDO ETHYLENE GLYCOL HETSYN ZNI RMC-7977 FORMUL 5 GNP 2(C10 H17 N6 O13 P3) FORMUL 6 MG 2(MG 2+) FORMUL 9 EDO C2 H6 O2 FORMUL 10 ZNI 2(C47 H60 N8 O6 S) FORMUL 12 HOH *933(H2 O) HELIX 1 AA1 GLY A 15 ASN A 26 1 12 HELIX 2 AA2 GLN A 61 MET A 67 5 7 HELIX 3 AA3 ARG A 68 GLY A 75 1 8 HELIX 4 AA4 ASN A 86 ASP A 92 1 7 HELIX 5 AA5 ASP A 92 ASP A 105 1 14 HELIX 6 AA6 ASP A 126 GLY A 138 1 13 HELIX 7 AA7 GLY A 151 GLU A 168 1 18 HELIX 8 AA8 GLY B 15 ASN B 26 1 12 HELIX 9 AA9 GLN B 61 MET B 67 5 7 HELIX 10 AB1 ARG B 68 GLY B 75 1 8 HELIX 11 AB2 ASN B 86 ASP B 105 1 20 HELIX 12 AB3 ASP B 126 GLY B 138 1 13 HELIX 13 AB4 GLY B 151 GLU B 168 1 18 HELIX 14 AB5 VAL C 29 GLY C 42 1 14 HELIX 15 AB6 THR C 119 ASP C 123 5 5 HELIX 16 AB7 GLY C 135 GLU C 143 1 9 HELIX 17 AB8 ARG C 144 GLY C 146 5 3 HELIX 18 AB9 VAL D 29 GLY D 42 1 14 HELIX 19 AC1 THR D 119 ASP D 123 5 5 HELIX 20 AC2 GLY D 135 GLU D 143 1 9 HELIX 21 AC3 ARG D 144 GLY D 146 5 3 SHEET 1 AA1 6 GLU A 37 ILE A 46 0 SHEET 2 AA1 6 GLU A 49 THR A 58 -1 O LEU A 53 N LYS A 42 SHEET 3 AA1 6 THR A 2 GLY A 10 1 N TYR A 4 O ASP A 54 SHEET 4 AA1 6 GLY A 77 ALA A 83 1 O VAL A 81 N VAL A 9 SHEET 5 AA1 6 MET A 111 ASN A 116 1 O ASN A 116 N PHE A 82 SHEET 6 AA1 6 PHE A 141 GLU A 143 1 O ILE A 142 N LEU A 113 SHEET 1 AA2 6 GLU B 37 ILE B 46 0 SHEET 2 AA2 6 GLU B 49 THR B 58 -1 O LEU B 53 N LYS B 42 SHEET 3 AA2 6 THR B 2 GLY B 10 1 N TYR B 4 O ASP B 54 SHEET 4 AA2 6 GLY B 77 ALA B 83 1 O VAL B 81 N VAL B 9 SHEET 5 AA2 6 MET B 111 ASN B 116 1 O ASN B 116 N PHE B 82 SHEET 6 AA2 6 PHE B 141 GLU B 143 1 O ILE B 142 N LEU B 113 SHEET 1 AA3 8 ARG C 55 ILE C 57 0 SHEET 2 AA3 8 MET C 61 GLY C 64 -1 O GLN C 63 N ARG C 55 SHEET 3 AA3 8 PHE C 112 CYS C 115 -1 O ILE C 114 N CYS C 62 SHEET 4 AA3 8 ILE C 97 MET C 100 -1 N ILE C 97 O CYS C 115 SHEET 5 AA3 8 VAL C 128 GLU C 134 -1 O GLY C 130 N LEU C 98 SHEET 6 AA3 8 GLU C 15 LEU C 24 -1 N SER C 21 O LYS C 133 SHEET 7 AA3 8 THR C 5 VAL C 12 -1 N ILE C 10 O LEU C 17 SHEET 8 AA3 8 ILE C 156 GLU C 165 -1 O ASP C 160 N ASP C 9 SHEET 1 AA4 8 PHE D 53 ILE D 57 0 SHEET 2 AA4 8 MET D 61 GLY D 64 -1 O GLN D 63 N ARG D 55 SHEET 3 AA4 8 PHE D 112 CYS D 115 -1 O ILE D 114 N CYS D 62 SHEET 4 AA4 8 ILE D 97 MET D 100 -1 N ILE D 97 O CYS D 115 SHEET 5 AA4 8 VAL D 128 GLU D 134 -1 O GLY D 130 N LEU D 98 SHEET 6 AA4 8 GLU D 15 LEU D 24 -1 N SER D 21 O LYS D 133 SHEET 7 AA4 8 THR D 5 VAL D 12 -1 N ILE D 10 O GLY D 18 SHEET 8 AA4 8 ILE D 156 LEU D 164 -1 O ASP D 160 N ASP D 9 LINK OG SER A 17 MG MG A 202 1555 1555 2.07 LINK OG1 THR A 35 MG MG A 202 1555 1555 2.08 LINK O1G GNP A 201 MG MG A 202 1555 1555 2.02 LINK O2B GNP A 201 MG MG A 202 1555 1555 2.08 LINK MG MG A 202 O HOH A 332 1555 1555 2.07 LINK MG MG A 202 O HOH A 366 1555 1555 2.05 LINK OG SER B 17 MG MG B 202 1555 1555 1.99 LINK OG1 THR B 35 MG MG B 202 1555 1555 1.92 LINK O1G GNP B 201 MG MG B 202 1555 1555 2.03 LINK O2B GNP B 201 MG MG B 202 1555 1555 2.00 LINK MG MG B 202 O HOH B 329 1555 1555 2.18 LINK MG MG B 202 O HOH B 334 1555 1555 2.03 CRYST1 65.757 84.240 125.980 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015208 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011871 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007938 0.00000